Assignee
GENETIC DIAGNOSTICS AND THERAPY 21 LTD
GB·2 granted patents·2 pending applications·0 citations·filing 2019–2021
Top patents by PatentIndex Score
4 records- 0136US2025195690A1Gene therapy DNA vector based on gene therapy DNA vector GDTT1.8NAS12 carrying HFE therapeutic gene for enhanced expression of the therapeutic gene, method of its production and use, Escherichia coli strain JM110-NAS/GDTT1.8NAS12-HFE carrying the gene therapy DNA vector, method of its production, method of the gene therapy DNA vector production on an industrial scaleGENETIC DIAGNOSTICS AND THERAPY 21 LTD·Filed 2021·Application pending·0 cites
- 0232US12246073B2DNA vector for targeted gene therapyGENETIC DIAGNOSTICS AND THERAPY 21 LTD·Filed 2019·Granted Mar 11, 2025·0 cites·1 claims
- 0332US11203760B2Gene therapy DNA vector GDTT1.8NAS12 and the method for obtaining thereofGENETIC DIAGNOSTICS AND THERAPY 21 LTD·Filed 2019·Granted Dec 21, 2021·0 cites·7 claims
- 0432US2026041789A1Gene therapy DNA vector based on gene therapy DNA vector GDTT1.8NAS12 carrying the therapeutic gene selected from the group of DDC, IL10, IL13, IFNB1, TNFRSF4, TNFSF10, BCL2, HGF, and IL-2 genes for increasing the expression level of these therapeutic genes, method of its production and use, Escherichia coli strain JM110-NAS/GDTT1.8NAS12-DDC, or Escherichia coli strain JM110-NAS/GDTT1.8NAS12-IL10, or Escherichia coli strain JM110-NAS/GDTT1.8NAS12-IL13, or Escherichia coli strain JM110-NAS/GDTT1.GENETIC DIAGNOSTICS AND THERAPY 21 LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GENETIC DIAGNOSTICS AND THERAPY 21 LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →